table2. Clinical course of three patients.
Transaminase , HBV-DNA and glood glucose , body weight.
Case 1) |
month |
-10 |
-0.5 |
0.5 |
1 |
2 |
3 |
4 |
|
BS mg/dl |
|
199 |
162 |
191 |
290 |
353 |
663 |
|
FBS mg/dl |
90 |
|
|
|
|
|
|
|
HbA1c % |
|
|
|
|
|
|
14.3 |
|
AST IU/L |
38 |
350 |
163 |
30 |
23 |
20 |
26 |
|
ALT IU/L |
77 |
821 |
467 |
48 |
33 |
27 |
32 |
|
GTP IU/L |
81 |
114 |
293 |
98 |
52 |
38 |
45 |
|
HBV-DNA Amplicor |
|
7 |
3.8 |
3.4 |
2.6 |
|
2.6 |
|
body weight kg |
84.5 |
|
80 |
|
|
|
69.4 |
Case 2) |
month |
-5 |
0 |
2 |
5 |
8 |
12 |
19 |
|
BS mg/dl |
|
135 |
240 |
204 |
268 |
|
|
|
FBS mg/dl |
101 |
|
|
|
133 |
97 |
101 |
|
HbA1c % |
|
|
5.7 |
|
5.7 |
4.6 |
4.5 |
|
AST IU/L |
32 |
31 |
37 |
30 |
41 |
38 |
24 |
|
ALT IU/L |
17 |
20 |
66 |
46 |
64 |
65 |
15 |
|
GTP IU/L |
60 |
66 |
85 |
65 |
92 |
42 |
20 |
|
HBV-DNA probe |
12 |
9.9 |
0.7 |
|
0.7 |
|
|
|
body weight kg |
67 |
67 |
65 |
|
65 |
58 |
55 |
Case 3) |
month |
-5 |
0 |
2 |
3 |
4 |
5 |
6 |
|
BS (ad lib) mg/dl |
|
|
|
396 |
469 |
|
|
|
FBS mg/dl |
125 |
115 |
136 |
|
|
185 |
128 |
|
HbA1c % |
7.2 |
7.3 |
|
|
11.8 |
10.7 |
8.3 |
|
AST IU/L |
150 |
93 |
62 |
47 |
51 |
30 |
|
|
ALT IU/L |
162 |
113 |
52 |
44 |
60 |
24 |
|
|
GTP IU/L |
55 |
48 |
27 |
28 |
40 |
|
|
|
HBV-DNA TMA |
|
8.3 |
|
|
|
<3.7 |
<3.7 |
|
body weight kg |
55 |
55 |
|
|
|
47 |
|
XV 02.8.19